Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: Fore Biotherapeutics
Cancer Harboring BRAF Alterations · HGG · LGG · Solid Tumors
United States, Australia, Canada, France, Germany +7 more
Sponsor: Avidity Biosciences, Inc.
Facioscapulohumeral Muscular Dystrophy · FSHD · FSHD - Facioscapulohumeral Muscular Dystrophy · FSHD1
United States, Canada, Denmark, France, Germany +5 more
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Parkinson Disease
United States, Austria, Canada, Germany, Greece +7 more
- A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab ProphylaxisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Severe Hemophilia A · Moderate Hemophilia A
United States, Brazil, Canada, Germany, Hungary +7 more
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +24 more
Sponsor: Asklepios proresearch
Placenta Previa
Germany
Sponsor: AbbVie
Relapsed or Refractory Multiple Myeloma
United States, Australia, Canada, France, Germany +8 more
Sponsor: AstraZeneca
Multiple Sclerosis
United States, Australia, Canada, Germany, United Kingdom
Sponsor: AbbVie
Psoriatic Arthritis
France, Germany, Greece, Italy
Sponsor: AstraZeneca
Healthy Participants
Germany
- Long-term Extension of GTX-102 in Angelman SyndromeEnrolling By Invitation
Sponsor: Ultragenyx Pharmaceutical Inc
Angelman Syndrome
United States, Australia, Canada, France, Germany +3 more
- Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)Active Not Recruiting
Sponsor: Vanda Pharmaceuticals
Sleep Wake Disorders · Sleep Disorders, Circadian Rhythm · Chronobiology Disorders
United States, Austria, Germany
- A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo NodularisTerminated
Sponsor: Amgen
Prurigo Nodularis
United States, Argentina, Australia, Austria, Belgium +25 more
- SIRONA 2 Trial Heart Failure NYHA Class IIIActive Not Recruiting
Sponsor: Endotronix, Inc.
Heart Failure NYHA Class III
Belgium, Germany, Ireland
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationActive Not Recruiting
Sponsor: Boston Scientific Corporation
Persistent Atrial Fibrillation
United States, Australia, Austria, Belgium, Canada +8 more
Sponsor: Janssen Research & Development, LLC
Myasthenia Gravis
United States, Australia, Belgium, Canada, China +12 more
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +11 more
Sponsor: Alfasigma S.p.A.
Rheumatoid Arthritis
United States, Argentina, Australia, Belgium, Bulgaria +27 more
Sponsor: Alaa Emara
Tonsillitis · Tonsillectomy · Tonsillitis Recurrent
Germany
- Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)Active Not Recruiting
Sponsor: Amgen
Relapsing-remitting Multiple Sclerosis (RRMS)
United States, Belgium, Bulgaria, Canada, Croatia +17 more
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
United States, Argentina, Belgium, Brazil, Denmark +6 more
Sponsor: UCB Biopharma SRL
Epilepsy
United States, Belgium, Czechia, France, Germany +6 more
- Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus ErythematosusActive Not Recruiting
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Argentina, Bulgaria, Chile, Colombia +10 more